Margin trendWarning
영업외손익 급변 (영업이익 대비 40% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Beauty Skin
A406820 · KOSDAQ₩1,869-0.74%
2026-08-25 closeBeauty Skin — what's the grade? And what signals are flashing today?
The grade and valuation bands are below — free to read.
Loading chart…
Close
AI Insight
Why these signals fired — only backtest-proven edge, told honestly
New high + volume — the real recordrecord · not a prediction
Not this one stock, but every new-high-plus-volume pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-25)
Last 30 sessions
402 picks
Next-day win rate
51.6%
Avg next-day
-0.06%
vs market
-0.24%p
Beat the market on 45.3% of picks (each pick vs its own day’s market average).
Recent publish days (next-day win rate)
08-23 60%08-21 36.4%08-20 44.4%08-19 0%08-18 27.3%08-14 23.1%08-13 41.7%08-12 70%08-11 77.8%08-10 22.2%08-07 61.5%08-06 27.3%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Trade plan
Decide the exit before you enter. Set what you are willing to lose first, and the share count follows — so you know the worst case before you buy.
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
This is a calculator, not advice, and it does not promise any outcome. You choose the stop and target — the button values (ATR, recent low/high) are observations from past prices. Actual fills depend on the order book and liquidity.
Valuation Grades
Relative to 108 화학 peers · not investment advice
F
Overall: 화학 105/108 · top 97%
Factor composite · relative position in sector
Financial safety
Reference indicatorAs of 2024Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 0.58
Distress
Grey
Safe
- Altman Z''
- 0.58
- Beneish M-Score
- -3.61
- Sloan accrual
- -16.81%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
5/9Moderate
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score5/9
Profitability
- Positive ROANot passed
- Positive OCFPass
- Improving ΔROAPass
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioPass
- No new sharesNot passed
Efficiency
- Higher gross marginPass
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Factual information, not investment advice.
Industry structure
KRAs of 2026-08-25화학
This stock is in 화학: revenue rank 76 of 107, share 0.1%.
76 / 1070.1%revenue share
Who dominates this industry?
- 1LG화학31.9%
- 2롯데케미칼13.3%
- 3금호석유화학4.7%
- 4DL3.7%
- 5코오롱인더3.2%
- 6뷰티스킨0.1%
Concentration
DistributedCR3 49.9%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
MixedConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 8.7
- Direction
- 확대
- Level
- 보통
- Years
- 6
Value lens
- P90/P10
- 9.6
- Median P/B
- 0.68
- Level
- 넓음
- n
- 95
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- -4.3%
- Interest coverage
- -2.1x
- Return on equity (ROE)
- -14.8%
Operating margin −5pp
Operating lossInterest coverageBase -2.1x adverse case -4.5x
Return on equity (ROE)Base -14.8% adverse case -26.8%
Revenue −15%
Interest coverage riskInterest coverageBase -2.1x adverse case -1.8x
Return on equity (ROE)Base -14.8% adverse case -13.4%
Interest rate +2pp
Interest coverage riskInterest coverageBase -2.1x adverse case -1.3x
Return on equity (ROE)Base -14.8% adverse case -17.8%
Interest coverage limit
Already below the limit by 6.3ppInterest coverage limit at an operating margin of 2%
Interest expense coverage threshold
Key suppliers · Annual report
Annual reportDART · 2026-03-19Suppliers disclosed by the company in its 2026-03-19 annual report.
Suppliers without disclosed amount
OEMODM
Financials at a glance
Beauty Skin's latest results and balance sheet. The bars track the last three periods.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
5%+ major-holding disclosures
- 김종수43.25%2025-10-16 · 증감 -3.74%p
- 글로벌강소기업키움엠앤에이전략창업벤처전문사모투자12.81%2026-01-15 · 증감 -1.01%p
- 하우자산운용6.45%2024-11-13 · 증감 +6.45%p
- 라이프자산운용5.36%2026-08-04 · 증감 +5.36%p
- 수성자산운용5.14%2026-07-30 · 증감 +5.14%p
Other stocks held by the same investors
A filing-based shared-holder record, not investment advice.
- 팸텍KRA271830 →
Shared holders: 라이프자산운용 · 수성자산운용
- 오픈놀KRA440320 →
Shared holders: 라이프자산운용 · 수성자산운용
- 한창제지KRA009460 →
Shared holders: 수성자산운용
- 영흥KRA012160 →
Shared holders: 수성자산운용
- 성호전자KRA043260 →
Shared holders: 수성자산운용
- 디에스엠KRA104040 →
Shared holders: 수성자산운용
- 율촌KRA146060 →
Shared holders: 수성자산운용
- NEWKRA160550 →
Shared holders: 수성자산운용
Recent filings
Beauty Skin's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy